Run Zhuang

Company: Unlearn.AI

Job title: Biostatistician

Seminars:

Use of Digital Twins in a Phase 2a Trial to Predict Disease-Progression of Participants with Mild-to-Moderate AD Supports Early Signals of Efficacy 2:00 pm

Machine learning-generated digital twins of disease progression which can be seamlessly integrated across different stages of clinical development In this study, we demonstrate the utility of digital twins in a Phase 2a trial of REM0046127, a small molecule designed to restore the integrity of septin filaments in neurons affected by Alzheimer’s disease Digital twins validated…Read more

day: Conference Day One - Track Three